Champions Oncology Presents
Innovations in Radiopharmaceuticals: a Translational Oncology Symposium
Tuesday, September 17th, 2024
11:00 AM - 3:00 PM
11:00 AM - 3:00 PM
Cambridge Innovation Center
1 Broadway & 245 Main Street
Cambridge, MA 02142
About Champions' Translational Oncology Symposium
We are excited to invite you to our Translational Oncology Symposium focused entirely on radiopharmaceutical research and development. This symposium will spotlight the latest advancements in radioligand therapy, bringing together top experts, researchers, and innovators. Enjoy an afternoon of compelling presentations, interactive discussions, and excellent networking opportunities. After the final talk, join us for complimentary drinks and hors d'oeuvres to continue the conversation. Your presence will play a key role in advancing cancer treatment and accelerating new therapies. We look forward to welcoming you to this important event.
Meeting Objectives:
- Advancement in Oncology: Learn from industry experts how radiopharmaceuticals represent a major breakthrough in cancer treatment by combining a cancer-targeting agent with a radioactive isotope, offering advantages over traditional therapies.
- Scientific Focus: The meeting is aimed to address challenges in radiopharmaceutical cancer therapy and promote significant advancements in cancer science through scientific collaborations.
- Industry Engagement and Networking: The field is expanding with increasing involvement from major pharmaceutical companies and the meeting is aimed to foster formal and informal interactions among leading experts from biopharma companies.
- 11:00 - 11:15 AM: Registration
- 11:15 – 11:30 AM: Opening Remarks & Welcome
Frank Smith, PhD, MBA
VP Business Development, East Coast US & European Territories
Champions Oncology
- 11:30 - 12:00 PM: It's More Than Affinity: The Art of Binding Radiopharmaceuticals with Precision and Passion
Shawn Hillier, PhD
EVP & Head of Preclinical Development
Ratio Therapeutics
- 12:00 - 12:30 PM: Complimentary Buffet Lunch
- 12:30 - 1:00 PM: Translational Research in Radiopharmaceutical Development: An Industry Perspective in Navigating the Frontiers of Therapeutic Innovation
Dr. Benedetta Arno
Lead Scientist
Medicines Discovery Catapult - 1:00 - 1:30 PM: Radiomers: A New Class of Radiopharmaceuticals Leveraging a Novel Ligand Discovery Platform
Atul Varadhachary, MD, PhD
President & CEO
Radiomer Therapeutics, Inc. - 1:30 - 2:00 PM: Modelling Patient Selection through Multiparametric Preclinical Refinement
Stefano Cairo, PhD
Senior Global Scientific Director
Champions Oncology
- 2:00 - 3:00 PM: Closing Remarks and Complimentary Happy Hour